The Golden Globes are known for their glitz, glamour, and unforgettable moments on the red carpet. But this year, it wasn’t just designer gowns and sparkling jewels making headlines—it was Ozempic. Yes, the diabetes medication turned weight-loss phenomenon has found its way into Hollywood conversations, raising eyebrows and sparking debate about its influence on Tinseltown.

Why Is Ozempic the Talk of Hollywood?

For those unfamiliar, Ozempic (semaglutide) is an FDA-approved medication for managing type 2 diabetes. Its ability to mimic the GLP-1 hormone helps regulate blood sugar and control appetite. While its primary purpose is diabetes management, Ozempic’s side effect of significant weight loss has caught the attention of Hollywood’s elite—and it’s now making waves beyond the medical community.

Reports have surfaced suggesting that some stars are turning to Ozempic to slim down quickly for red carpet events. With its proven ability to help users shed up to 15% of their body weight, it’s easy to see why it’s being whispered about at celebrity dinner parties. But this trend has raised important questions about accessibility, health risks, and the ethical implications of using a life-saving medication for aesthetic purposes.

What Happened at the Golden Globes?

During this year’s Golden Globes, the conversation around Ozempic reached a fever pitch. Speculation swirled about who might be using it, with some social media users dubbing the event “the Ozempic Globes.” The whispers weren’t entirely unfounded—several attendees appeared noticeably slimmer, fueling discussions online and in the media.